Challenges and Prospects of Allogeneic CAR-T Cell Therapy

Time: 9:00 am - 12:00 pm


Whilst most success in CAR-T therapies is currently seen in the autologous space we are seeing a drive for progress in allogeneic CAR-T therapies.

Join us as we discuss:

  • Design for allo-CAR-T
  • Safety issue for Allo-CAR-T
  • Allo-CAR-T and its manufacture
  • Features and applications of uCAR-T